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Abstract
Purpose: Survivors of childhood cancer require life-long outpatient healthcare, which may be 
impacted by health insurance. This study sought to understand survivors’ utilization of outpatient 
healthcare provider services.
Methods: The study examined cross-sectional survey data using an age-stratified sample from 
the Childhood Cancer Survivor Study of self-reported annual use of outpatient services. 
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Multivariable logistic regression analyses were used to identify risk factors associated with 
utilization of services.
Results: 698 survivors were surveyed, median age 36.3 years (range 22.2–62.6), median time 
from diagnosis 28.8 years (range 23.1–41.7). Almost all (93%) of survivors had at least one 
outpatient visit during the previous year; 81% of these visits were with a primary care providers 
(PCP), 54.5% were with specialty care physicians, 30.3% were with nurse practitioner/physician’s 
assistants (NP/PA), and 14.2% were with survivorship clinic providers. Survivors with severe to 
life-threatening chronic health conditions had greater odds of utilizing a specialty care physician 
(OR=5.15, 95% CI 2.89–9.17) or a survivor clinic (OR=2.93, 95% CI 1.18–7.26) than those with 
no chronic health conditions. Having health insurance increased the likelihood of seeking care 
from NP/PA (Private, OR=2.76, 95% CI 1.37–5.58; Public, OR=2.09, 95% CI 0.85–5.11), PCP 
(Private, OR=7.82, 95% CI 3.80–13.10; Public, OR=7.24, 95% CI 2.75–19.05), and specialty care 
(Private, OR=2.96, 95% CI 1.48–5.94; Public, OR=2.93, 95% CI 1.26–6.84) compared to without 
insurance.
Conclusion: Most childhood cancer survivors received outpatient care from PCP, but a minority 
received care from a survivorship clinic provider. Having health insurance increased the likelihood 
of outpatient care.
Implications for Cancer Survivors: Targeted interventions in the primary care setting may 
improve risk-based, survivor-focused care for this vulnerable population.
Keywords
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Introduction
Over the last fifty years, major therapeutic advances have transformed the field of pediatric 
oncology. Improvement in overall survival has made it possible for more than eight of every 
ten children diagnosed with cancer to become five-year survivors of their primary 
malignancy[1]. As of 2011, there were estimated to be over 388,000 childhood cancer 
survivors in the United States, a number which could approach 500,000 survivors by 
2020[2,3]. Among these survivors, about 70% are over the age of 20 years[2]. It is 
imperative that primary care providers and specialists provide risk-based, survivor-focused 
care for childhood cancer survivors as they live into adulthood[4,5]. Such care is defined as a 
medical visit related to their prior cancer in which a screening test is discussed or ordered or 
the survivor is counseled on how to reduce his/her specific risks for late effects[5]. It is not 
clear how many childhood cancer survivors use or have access to this type of service within 
their primary care or specialty care follow-up arrangements.
Risk-based care is important for this vulnerable population in part because three quarters of 
long-term cancer survivors develop a chronic medical condition, with more than one-third 
suffering from a severe or life-threatening condition[6,7]. The rates of chronic medical 
conditions were found to be even higher than reported (95.5% for any chronic condition, 
80.5% for severe or life-threatening) when systematic risk-based medical assessments were 
performed on a subset of survivors[8]. Consequently, survivor-focused, risk-based healthcare 
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of aging adult survivors of childhood cancer should promote preventive care, early detection 
of late effects, and interventions to reduce morbidity or mortality of late effects of 
therapy[4,9].
While survivor-focused care may be provided in survivor-focused clinics, these specialized 
clinics may not be accessible to all survivors into adulthood. Survivor-focused care can be 
provided in many different settings including from a knowledgeable primary care physician 
(PCP) or nurse practitioner (NP); therefore understanding whom survivors are actually 
receiving care from will provide insights for understanding the best locus of care, and the 
need for future care coordination, and integration across primary and specialty care services.
Despite its importance, accessing primary or preventive services may be especially difficult 
for survivors because they may have difficulties obtaining adequate health insurance 
coverage. Multiple studies have documented the challenges faced by individuals with 
chronic illness in acquiring adequate and affordable health insurance coverage[10–15]. In 
2005, Park et al. found that 29% of childhood cancer survivors reported having difficulty 
obtaining coverage as compared with a sibling cohort rate of only 3%[16]. The combination 
of a growing number of adult survivors of childhood cancer experiencing chronic medical 
conditions and lack or potential inadequacy of health insurance coverage poses a complex 
problem for the healthcare system. In 2012, the Affordable Care Act (ACA) incorporated 
new provisions into healthcare legislation to ensure coverage for those with pre-existing 
medical conditions and to improve their ability to obtain and maintain insurance[17]. 
Unfortunately, it is unclear whether proposals for ACA repeal and replacement will preserve 
the provisions intended to benefit childhood cancer survivors. Therefore, understanding the 
utilization of healthcare by survivors, and how healthcare patterns are influenced by 
insurance status, will be important for designing future guidelines that assure appropriate 
healthcare at affordable cost.
Park et al. conducted the “Long Term Follow Up: Health Insurance Study” survey in 2011–
2012 as the ACA implementation was beginning[18]. In this publication, the investigators 
report on the utilization of outpatient healthcare services, including primary, specialty, and 
survivor-focused clinics by adult survivors of childhood cancer. The objectives were to 
quantify and describe outpatient healthcare utilization by adult survivors and identify 
survivor characteristics (chronic health conditions and insurance status) associated with 
outpatient healthcare utilization.
Methods
Study Design and Setting
This study was a cross-sectional survey administered as part of the Childhood Cancer 
Survivor Study (CCSS) performed between May 2011 and April 2012. All procedures were 
approved by the Institutional Review Boards of St. Jude Children’s Research Hospital and 
the Massachusetts General Hospital/Partners HealthCare[18].
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Study participants
The CCSS is a multi-institution, retrospective cohort with longitudinal follow-up, designed 
to investigate long-term outcomes in survivors of childhood cancer. Participants were 
initially diagnosed with childhood cancer at one of 26 institutions between 1970 and 1986, 
were younger than 21 years at diagnosis of leukemia, central nervous system malignancies, 
Hodgkin lymphoma, non-Hodgkin lymphoma, kidney cancer, neuroblastoma, soft tissue 
sarcoma or bone cancer, and survived greater than five years after diagnosis[19,20]. For this 
study, 1,101 survivors within the CCSS were randomly selected from three age strata (22–29 
years, 30–39 years, ≥40 years). Of these, 698 survivors (70%) completed the paper- or web-
based survey (see reference for CONSORT diagram)[18].
Measures
The survey instrument was designed utilizing information from an initial qualitative 
study[21] and national surveys[22–26] with pilot testing among adult childhood survivors 
treated at Massachusetts General Hospital. Two versions of the survey were administered 
(insured or uninsured) depending upon the response to the first survey question, “Do you 
currently have health insurance that covers doctor and hospital care?” (https://
ccss.stjude.org/tools-and-documents/questionnaires/original-cohort-questionnaires.html).
Participant demographic and clinical characteristics
Participant information was collected including sex, age at time of survey, race/ethnicity, 
current marital status, employment status, household income, and insurance characteristics. 
Treatment exposures were abstracted from medical records, and chronic health conditions 
were obtained from the CCSS follow-up 4 survey, administered in 2007[6,7,20]. Chronic 
health conditions were assigned severity scores based on the Common Terminology Criteria 
for Adverse Events (version 4.03, National Cancer Institute)[27]. The conditions were 
graded as mild (grade 1), moderate (grade 2), severe or disabling (grade 3), life-threatening 
(grade 4), or fatal (grade 5). For the analysis, chronic health conditions were categorized into 
mutually exclusive categories of: none, presence of any mild to moderate condition (grade 
1–2), or presence of a severe to life-threatening condition (grade 3–4). Health insurance was 
classified as: private (including employer sponsored, military, or individual), public 
(including Medicare or Medicaid, but participant is not covered by a private insurance plan), 
and none.
Study Outcomes
Participants were asked a series of questions related to the outpatient healthcare they had 
received in the previous year, including which types of healthcare providers they had “seen 
or talked to for medical care (either routine or sick care).” Responses included: no outpatient 
visits, nurse practitioner/physician’s assistant (NP/PA), primary care physician (PCP), 
specialty care physician, a provider who sees cancer survivors for routine follow-up care 
(e.g. survivorship clinic provider), or other (with fill-in space provided). Visits were 
analyzed based on whether there were seen by each type of provider (NP/PA, PCP, specialty 
care physician, survivorship clinic provider). Participants were also asked how many of their 
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visits were due to their previous illness of cancer; their responses were dichotomized to at 
least one due to previous illness versus none.
Statistical Analysis
All statistical analyses were performed using Stata version 13 (Stata, College Station, TX), 
incorporating weighting based on the distribution of age in the original CCSS cohort to 
achieve proportions representative of the entire original CCSS cohort[18]. Not all 
participants had complete data; those with missing data were not included in the logistic 
regression analyses. All p-values are two-sided and considered significant if less than 0.05.
Descriptive statistics were used to characterize demographic and clinical characteristics of 
survivors. The proportions of survivors who were evaluated by each type of outpatient 
healthcare provider were calculated, overall and by demographic and clinical characteristics. 
Frequency of visits to providers for those with at least one visit were determined. The 
investigators examined if there was an association between having a visit due to their 
previous cancer and which types of outpatient providers were seen. Separate weighted (i.e., 
on age at diagnosis) multivariable logistic regression were performed for each type of 
outpatient provider visit (NP/PA, PCP, specialty care physicians, and survivorship clinic 
providers) treated as dichotomous outcomes to evaluate associated factors. Explanatory 
variables in regression modeling were selected a priori based on hypothesized clinical 
relevance and previous publications[5, 28, 29], which included: sex, health condition status, 
insurance status, patient age at time of survey, race/ethnicity, and household income.
Results
Participant Characteristics
The majority of survivors were female and white/non-Hispanic (Table 1). Almost half of 
participants were between the ages of 40–62 years at the time of the survey. Leukemia was 
the most common primary cancer diagnosis. The median time since diagnosis was 28.8 
years (range 23.1–41.7 years). 39.8% of survivors in this study had severe to life-threatening 
conditions, with 45.1% experiencing mild to moderate conditions; 15.1% did not report a 
chronic health condition. In terms of insurance, 10.3% of survivors did not have health 
insurance, 10.6% had public insurance, and 79% had private insurance.
Outpatient Providers Seen by Childhood Cancer Survivors
Respondents were also asked about their outpatient healthcare service utilization during the 
year prior to the survey, with 81.3% of survivors seen by a PCP, 54.5% seen by a specialty 
care physician, 30.3% seen by a NP/PA, and 14.2% seen by a survivorship clinic provider 
(Table 2). About a quarter (28.6%) of survivors were seen only by a PCP, 3.8% were seen 
only by a specialty care physician, and 0.6% were seen only by a survivorship clinic 
provider. Seven point two percent had no outpatient provider visits in the one-year timespan. 
For survivors with at least one outpatient visit, the median frequency of visits to a PCP was 2 
(IQR 1–4, max 35), specialty care physician were 2 (IQR 1–4, max 40), and survivorship 
clinic provider were 0 (IQR 0–1, max 26). However, 27.2% of uninsured survivors received 
no outpatient healthcare in a year.
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Higher proportions of female survivors were seen by each of the types of providers (NP/PA, 
PCP, specialty care physician, and survivorship clinic provider) as compared to males. For 
each different type of provider visits, survivors with severe to life-threatening chronic health 
conditions had higher proportions of seeking care compared to those with no conditions. 
Participants who indicated they were uninsured had the lowest proportion of seeking all 
types of providers compared to all other forms of known health insurance.
Nearly 40% of participants stated that at least one of their outpatient provider visits was 
related to their previous cancer. Survivors with at least one visit due to cancer had 
significantly higher proportions of visits to specialty care providers (77.2%) and survivor 
clinic providers (37.5%) than those with no visits due to their previous diagnosis of cancer 
(specialty care physician 50.6%; survivorship care provider 2.0%). There were no major 
differences for primary care providers (at least one visit due to cancer 89.4%, none due to 
cancer 91.3%).
Factors Associated with Outpatient Provider Visits
In multivariable analyses, female survivors were more likely than male survivors to have an 
outpatient provider visit with an NP/PA (OR=1.46, 95% CI 0.92–2.33) or specialty care 
providers (OR=1.54, 95% CI 1.07–2.22) compared to males (Table 3). Participants with mild 
to moderate chronic health conditions had a higher odds of a visit to a NP/PA (OR=2.07, 
95% CI 1.13–3.79), a PCP (OR=2.29, 95% CI 1.20–4.36), and specialty care providers 
(OR=2.18, 95% CI 1.26–3.77) compared to those without chronic health conditions. Those 
with severe to life-threatening chronic health conditions had higher odds of a visit to a 
specialty care physician (OR=5.15, 95% CI 2.89–9.17) and to a survivor clinic (OR=2.93, 
95% CI 1.18–7.26) compared to those with no chronic health conditions. Insured survivors 
had higher odds of having a visit with an NP/PA (Private, OR=2.76, 95% CI 1.37–5.58; 
Public, OR=2.09, 95% CI 0.85–5.11), a PCP (Private, OR=7.82, 95% CI 3.80–13.10; Public, 
OR=7.24, 95% CI 2.75–19.05), and a specialty care physician (Private, OR=2.96, 95% CI 
1.48–5.94; Public, OR=2.93, 95% CI 1.26–6.84) compared to those without insurance.
Discussion
In this study of outpatient healthcare utilization among childhood cancer survivors, it was 
found that nearly 40% of participants had at least one outpatient visit within the previous 
year that was related to their previous cancer. The vast majority of survivors (81.3%) were 
seen by a PCP, over half saw a specialist, but only 14.2% reported being seen at a 
survivorship clinic. While there are clear guidelines for the types and frequencies of risk-
based screening and surveillance for childhood cancer survivors, the exact location of where 
this care is provided is not well outlined[29]. Limited evaluations among adult cancer 
survivors have not determined the most effective combination of care providers either[30]. 
This study suggests that the provision of the recommended risk-based, survivor-focused care 
may be most practically delivered by primary care providers who see the majority of adult 
survivors of childhood cancer.
The current literature among adult survivors of childhood cancer shows gaps in the receipt of 
survivor-focused care. For example, in an analysis of the baseline CCSS questionnaire, 
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Oeffinger discovered that while 87% of survivors reported attending a “general medical 
visit,” only 41.9% had received a “cancer-related visit” in the last two years[31]. Nathan et 
al. found that only 31.5% reported care that focused on their previous cancer, and only 
17.8% reported survivor-focused care that included advice about risk reduction or discussion 
or ordering of screening tests[5]. Evidence suggests that primary care providers may be 
willing to provide long-term follow-up care, but many are not adequately prepared to 
provide survivor-focused care[32–34]. While the present study did not address survivor-
focused care specifically, the investigators believe the finding that the majority of adult 
survivors of childhood cancer are receiving care by primary care providers, but not at 
survivorship clinics, seems to indicate that increased efforts should target survivor-focused 
care in the primary care setting. Therefore, multi-disciplinary approaches, such as the 
inclusion of a trained NP or PA, combined with patient engagement through survivorship 
care plans may be needed to achieve optimal care[6,35].
It also determined that about one-third of adult survivors of childhood cancer had a visit with 
an NP/PA in the last year. While this study was limited in the analysis due to the location of 
outpatient care provided by NP/PA’s, their role in the care of adult survivors is important. 
Several studies have revealed that NP’s are more likely to provide care in a wide range of 
community settings, including rural locations, suggesting that NP’s could fill the 
survivorship care role if access to physicians is limited by geography[36,37]. An NP or PA 
who is knowledgeable in the follow up of survivors could play a large role in the provision 
of care that is required, but not currently being accomplished[5].
Care seeking should be determined by one’s health status, presumably that survivors’ 
healthcare utilization would correspond to their chronic health burden. While it was found 
that those survivors with chronic health conditions were more likely to seek services, gender 
and health insurance status were also significant factors. Specifically, survivors with 
insurance coverage had increased odds of having a visit to a PCP and a specialty care 
physician, suggesting that insurance coverage of any form may improve the receipt of 
outpatient care for survivors. Independent of the presence and grade of chronic health 
conditions, it was also found uninsured survivors are less likely than those with insurance to 
utilize outpatient medical providers. In recently published explorations of other aspects of 
the survey examined in this paper, Park et al. revealed that uninsured survivors experienced 
excess worry related to the cost of care, which translated into skipping or postponing 
medical care[38]. Those survivors with a higher percentage of income spent on out-of-
pocket medical costs were also more likely to defer medical care or skip a test, treatment, or 
follow up[39]. While health status should drive the receipt of medical care, it is clear that the 
cost of care and presence of insurance contribute to achieving good access and utilization of 
healthcare services.
While this study adds insight into the outpatient healthcare utilization by childhood cancer 
survivors, there are several important limitations. Survivors’ chronic health conditions, 
health insurance status, and types of providers seen were all self-reported. The types of 
outpatient providers seen does not necessarily determine the location of care, but it was 
assumed PCP’s were seen in the primary care setting. Participants were also asked how 
many of the visits were related to their previous cancer, but this question was not specific to 
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the types of providers seen. There were no specific questions in this survey addressing if 
advice was provided or screening was performed specifically addressing cancer-related 
sequelae. This study did not intend to imply differences in the quality of care provided based 
on the types of providers seen by survivors of childhood cancer. The investigators 
acknowledge that references to prior CCSS publications are not independent from this study 
given the potential for overlap in sample populations. This survey was completed prior to the 
complete implementation of the ACA which likely impacted insurance coverage for this 
population[16]. Lastly, this study analyzed a cohort of survivors who were treated at tertiary 
care centers and included a limited number of racial or ethnic minorities, although the cohort 
is representative of survivors in the CCSS.
Conclusion
In conclusion, the majority of childhood cancer survivors received care from primary care 
providers, but only 14.2% received care from a survivorship clinic provider. While the vast 
majority of survivors received outpatient healthcare over the one-year timespan studied, 
those with health insurance had much higher odds of receiving outpatient care by NP/PA, 
PCP, and specialty care physicians. While performed prior to complete implementation of 
the ACA, this analysis of outpatient healthcare utilization of survivors could be used to 
evaluate the impact of the ACA on actual healthcare utilization. Targeted interventions in the 
primary care setting may improve the rate of risk-based, survivor-focused care for this 
vulnerable population.
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Table 1.
Demographic and Treatment Characteristics of Childhood Cancer Survivors
N (Total = 698) % (Weighted†)
Age at survey, years
 22–29 214 11.3
 30–39 228 42.3
 40–62 256 46.2
Sex
 Female 384 54.5
 Male 314 45.5
Race/Ethnicity*
 White, non-Hispanic 646 93.6
 Black, non-Hispanic 14 1.7
 Hispanic/Latino 24 3.0
 Other 12 1.8
Education*
 High school or less 98 14.1
 Some college or more 179 26.8
 Completed college and above 352 59.1
Marital Status*
 Single, never married 240 28.5
 Married, living as married 393 61.3
 Widowed/Divorced/Separated 59 10.2
Household Income*
 <$20,000 91 12.0
 $20,000 - $39,999 106 14.9
 $40,000 - $59,999 104 15.8
 $60,000 - $79,999 95 14.8
 >=$80,000 240 38.4
 Don’t know 36 4.2
Type of Cancer
 Leukemia 255 35.0
 Central Nervous System 104 14.9
 Hodgkin lymphoma 71 12.9
 Neuroblastoma 67 6.1
 Wilms (Kidney) Tumor 66 8.1
 Soft tissue sarcoma 51 8.3
 Bone tumor 45 8.1
 Non-Hodgkin lymphoma 39 6.7
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N (Total = 698) % (Weighted†)
Age at diagnosis, years
 0–5 404 46.4
 6–10 104 19.1
 11–15 109 19.8
 16–20 81 14.7
Years since diagnosis, median (range) 28.8 (23.1–41.7)
Recurrence of primary malignancy
 Yes 87 11.9
 No 611 88.1
Subsequent neoplasm
 Yes 30 5.1
 No 668 94 9
Chronic Health Conditions
 None 111 15.1
 Mild to moderate (CTCAE Grades 1–2) 319 45.1
 Severe to life-threatening (CTCAE Grades 3–4) 268 39.8
Insurance
 Private 529 79.0
 Public 82 10.6
 None 79 10.3
*
Totals and percentages provided only for survivors who reported on the indicated characteristic
†
Percentages were weighted to reflect the population age distribution of the full original Childhood Cancer Survivor Study cohort;
CTCAE=Common Terminology Criteria for Adverse Events, Version 4.03
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Table 2.
Outpatient Provider Visits by Childhood Cancer Survivors.
Primary Care 
Physician 
N=556
Specialty Care 
Physician 
N=321
Nurse 
Practitioner/ 
Physician 
Assistant† N=208
Survivorship 
Clinic Provider 
N=97
No Outpatient 
Visits N=50
N
 %*
Overall 698 81.3 54.4 30.3 14.2 7.2
Age at survey, years
 22–29 214 76.5 51.1 29.1 13.1 7.0
 30–29 228 81.9 52.0 30.8 12.8 5.3
 40–62 256 81.9 57.3 30.0 15.8 9.1
Sex
 Female 384 84.2 60.3 36.7 16.7 4.7
 Male 314 77.7 47.3 22.6 11.3 10.2
Chronic Health Conditions
 None 111 70.9 30.1 19.8 8.0 16.5
 Mild to moderate 319 83.8 49.4 33.2 11.1 6.0
 Severe to life-threatening 268 82.4 69.2 31.0 20.1 5.0
Insurance
 Private 529 86.1 57.7 32.2 13.8 5.3
 Public 82 85.3 58.6 31.3 21.0 2.8
 None 79 44.2 26.5 18.3 7.0 27.2
Note: Columns are not mutually exclusive, percentages are by row to demonstrate the distribution of providers seen by independent characteristics
*
Percentages are weighted to reflect the population age distribution of the full original Childhood Cancer Survivor Study cohort
†
Primary care versus specialty care location of Nurse Practitioner/Physician Assistant visits was not specified on the survey
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Table 3.
Factors Associated with Outpatient Provider Visits Among Childhood Cancer Survivors
 Primary Care Physician  Specialty Care Physician  Nurse Practitioner/ Physician Assistant  Survivor Clinic Provider
OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value
Sex
 Female  1.46 (0.92–2.33) 0.11  1.54 (1.07–2.22) 0.02  1.86 (1.27–2.75) 0.002  1.46 (0.88–2.44)  0.14
Chronic Health Condition
 None Reference Reference Reference Reference
 Mild to Moderate  2.29 (1.20–4.36) 0.01  2.18 (1.26–3.77) 0.006  2.07 (1.13–3.79) 0.02  1.54 (0.61–3.90)  0.36
 Severe to life-threatening  1.77 (0.92–3.40) 0.09  5.15 (2.89–9.17) <0.001  1.67 (0.90–3.12) 0.10  2.93 (1.18–7.26)  0.02
Insurance
 None Reference Reference Reference Reference
 Private  7.82 (3.80–13.10) <0.001  2.96 (1.48–5.94) 0.002  2.76 (1.37–5.58) 0.005  2.96 (0.95–9.23)  0.06
 Public 7.24 (2.75–19.05) <0.001 2.93 (1.26–6.84) 0.01 2.09 (0.85–5.11) 0.11 3.57 (0.94–13.50)  0.06
Adjusted for: age at time of survey, race/ethnicity, household income
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